Andrew Fraley is a scientist, biotech entrepreneur, and advisor who plays a multifaceted role in the biotech industry. Currently, they serve as the founding and managing partner at Sunrise Bioventures and hold positions as Chief Strategy Officer at Shift Bioscience and board observer at Radar Therapeutics. Andrew has previously co-founded and led companies such as Judo Bio and Korro Bio, focusing on RNA delivery and precision therapeutics. With a strong academic foundation in chemistry and bioorganic chemistry, Andrew has contributed to numerous biotech ventures, working closely with venture capital teams and mentoring within the community.
This person is not in the org chart
This person is not in any teams
This person is not in any offices